Stryker Corporation (SYK) Covered Calls

Stryker Corporation covered calls Stryker Corporation is a global medical technology leader specializing in MedSurg, Neurotechnology, and Orthopaedics. The company develops innovative surgical equipment, orthopedic implants, and neurovascular devices used in over 75 countries. By integrating advanced robotics and digital health platforms, Stryker enhances clinical workflows and patient outcomes, maintaining a track record of strong organic growth and strategic acquisitions.

You can sell covered calls on Stryker Corporation to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for SYK (prices last updated Fri 4:16 PM ET):

Stryker Corporation (SYK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
366.05 +0.20 355.00 376.29 2.3M 48 140
Covered Calls For Stryker Corporation (SYK)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Feb 20 370 1.70 374.59 -1.2% -54.8%
Mar 20 370 8.60 367.69 0.6% 6.1%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Stryker Corporation (SYK) is a premier global medical technology company dedicated to making healthcare better through innovation and operational excellence. The company utilizes a decentralized operating model that empowers specialized business units to respond rapidly to clinician needs. This structure has enabled Stryker to consistently deliver top-tier organic growth while integrating a steady stream of strategic acquisitions that expand its technological moat across the surgical and hospital environment.

Core Business and Operating Segments

  1. MedSurg and Neurotechnology: This diverse segment is the company’s largest revenue engine, providing critical infrastructure for the modern hospital. It includes surgical power tools, endoscopic visualization systems, and medical beds, alongside life-saving neurovascular devices. The segment is increasingly defined by digital integration, featuring AI-assisted communication platforms and advanced systems that improve operating room efficiency and patient safety.
  2. Orthopaedics and Spine: A global powerhouse in joint replacement, Stryker provides high-performance implants for hips, knees, and extremities. The centerpiece of this segment is the Mako Robotic-Arm Assisted Technology. By creating a "flywheel" effect—where robotic installations drive increased demand for proprietary implants—Stryker has captured significant market share in both traditional hospitals and rapidly growing ambulatory surgery centers (ASCs).

Competitive Landscape

Stryker operates in a high-barrier market where brand loyalty and technical precision are paramount. Its most direct competitor in the diversified medtech space is Medtronic, which challenges Stryker in spine and neurovascular sectors. In the orthopedic arena, it faces intense rivalry from Zimmer Biomet and Johnson & Johnson. For surgical visualization and sports medicine, it contends with Boston Scientific and Smith & Nephew. Additionally, in the specialized robotic surgery and capital equipment markets, it is frequently compared to Intuitive Surgical.

Strategic Outlook and Innovation

Stryker’s long-term strategy is anchored by "Category Leadership and Cost Transformation." The company reinvests significantly in R&D to maintain a multi-year pipeline of product launches, such as advanced camera platforms and modular plating systems. A key pillar of its growth is the integration of "smart" technologies into the hospital environment, creating ecosystems that link pre-operative planning to intra-operative execution. Financially, Stryker prioritizes margin expansion through operational efficiencies while returning capital to shareholders through a growing dividend. By focusing on high-growth areas like vascular health and robotic-assisted surgery, Stryker remains positioned to benefit from favorable global demographics and the ongoing shift toward technology-enabled, value-based healthcare.